Abstract:Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Although a lower methylation level of whole genome has been demonstrated in TOF patients, little is known regarding the DNA methylation changes in specific gene and its associations with TOF development. NOTCH4 is a mediator of the Notch signalling pathway that plays an important role in normal cardiac development. However, the role of epigenetic regulation of theNOTCH4gene in the pathogenesis of TOF remains unclear. Considering theNOTCH4low mutation frequency and reduced expression in the TOF patients, we hypothesized that abnormal DNA methylation change ofNOTCH4gene may influence its expression and responsible for TOF development. In this study, we measured the promoter methylation status ofNOTCH4and was measured and its regulation mechanism was explored, which may be related to TOF disease. Additionally, the promoter methylation statuses ofNOTCH4was measured in order to further understand epigenetic mechanisms that may serve a role in the development of TOF. Immunohistochemical analysis was used to examine NOTCH4 expression in right ventricular outflow tract myocardial tissues in patients with TOF. Compared with healthy controls, patients with TOF displayed significantly reduced in NOTCH4 expression (P=0.0055). Moreover, bisulphite sequencing suggested that the methylation levels of CpG site 2 in theNOTCH4promoter was significantly higher in the patients than in the controls (P=0.0459). NOTCH4 expression was negatively associated with CpG site 2 methylation levels (r=-0.51; P=0.01). ETS1 transcription factor can serve as transcriptional activators by binding to specific DNA sequences of target genes, such asDLL4andNOTCH4, which serves an important role in normal heart development. Dual-luciferase reporter and electrophoretic mobility shift assays indicated that the ETS1 transcription factor could bind to theNOTCH4promoter region. However, binding of ETS1 to theNOTCH4promoter was abrogated by methylation at the putative ETS1 binding sites. These findings suggested that decreased NOTCH4 expression in patients with TOF may be associated with hypermethylation of CpG site 2 in theNOTCH4promoter region, due to impaired binding of ETS1.

The CpG Island Methylation Status Analysis in the Promoter Region of the Conotruncal Heart Malformation Candidate Gene NKX2-5

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

Genome-wide Methylation Analysis Reveals Differentially Methylated CpG Sites and Altered Expression of Heart Development-Associated Genes in Fetuses with Cardiac Defects

The Interaction Analysis of SNP Variants and DNA Methylation Identifies Novel Methylated Pathogenesis Genes in Congenital Heart Diseases

Csx/Nkx 2. 5 Gene Expression in Embryonic Hearts and Its Mutation in Congenital Heart Disease

Investigation Of Somatic Nkx2-5 Mutations In Chinese Children With Congenital Heart Disease

The Expression Profile Analysis of NKX2-5 Knock-out Embryonic Mice to Explore the Pathogenesis of Congenital Heart Disease.

The correlation between mutations in the promoter region of TBX 1 gene and conotruncal heart defects

Genome-wide DNA methylation analysis of discordant monozygotic twins reveals consistent sites of differential methylation associated with congenital heart disease

Mutation Screening of NKx 2.5 Gene and its Relationship to Simple Congenital Heart Disease in 81 Patients

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Search of Somatic Mutations of NKX2-5 and GATA4 Genes in Chinese Patients with Sporadic Congenital Heart Disease

Relationship of Methylation Within Upper Stream Region of Transcription Starts Site of HOXA5 Gene with Neural Tube Defects.

DNA Methylation Status of NKX2-5, GATA4 and HAND1in Patients with Tetralogy of Fallot

Identification Of Novel Single-Nucleotide Variants With Potential Of Mediating Malfunction Of Microrna In Congenital Heart Disease

DNA Methylation at CpG Island Shore and RXRα Regulate NR2F2 in Heart Tissues of Tetralogy of Fallot Patients.

The Genotype and Expression of the TGFβ2 Gene in Children With Congenital Conotruncal Defects

CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples

Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

Identification of FOXH1 Mutations in Patients with Sporadic Conotruncal Heart Defect

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect